Journal of Antibiotics Research

Dr. Martin Michaelis is presently working as a Professor in the Department of Cell Biology in University of Kent in United Kingdom. He had studied pharmacy and completed his PhD in pharmaceutics in Frankfurt am Main, Germany, working on drug carrier systems including nanoparticles and liposomes. Then, he took a post as postdoc at the Institute for Medical Virology, Clinics of the Goethe-University, Frankfurt/Main, Germany, and started to work on the identification and investigation of anti-cancer and antiviral drugs. From 2005, he joined the charity “Hilfe für krebskranke Kinder Frankfurt e.V.”, Frankfurt am Main, finally resulting in a joined affiliation at the private research institute of the charity’s trust Frankfurter Stiftung für krebskranke Kinder (Dr. Petra Joh-Forschungshaus) and at the Institute of Medical Virology in Frankfurt am Main.

Dr. Martin Michaelis research interests includes the investigation of a broad range of drugs in cell biology models from the fields of oncology, virology, immunology, and angiogenesis with an interest in colloidal drug delivery systems.  Martin has a focus on acquired drug resistance in cancer and beyond.